Cargando…
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole
IMPORTANCE: The combination of ceftriaxone and lansoprazole has been shown to prolong the corrected QT interval on electrocardiogram. However, it is unknown whether this translates to clinically important patient outcomes. OBJECTIVE: To compare lansoprazole with another proton pump inhibitor (PPI) d...
Autores principales: | Bai, Anthony D., Wilkinson, Amelia, Almufleh, Aws, Rai, Mandip, Razak, Fahad, Verma, Amol A., Srivastava, Siddhartha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603497/ https://www.ncbi.nlm.nih.gov/pubmed/37883084 http://dx.doi.org/10.1001/jamanetworkopen.2023.39893 |
Ejemplares similares
-
The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety
por: Leonard, Charles E., et al.
Publicado: (2020) -
The time is now: role of pragmatic clinical trials in guiding response to global pandemics
por: Almufleh, Aws, et al.
Publicado: (2021) -
Endo/epicardial ablation of ventricular arrhythmias with contact force-sensing catheters in arrhythmogenic right ventricular dysplasia/cardiomyopathy
por: Aras, Dursun, et al.
Publicado: (2019) -
Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators
por: Kawamura, Mitsuharu, et al.
Publicado: (2019) -
A case report of ceftriaxone-induced cardiopulmonary arrest
por: Abodunrin, Faith, et al.
Publicado: (2022)